Literature DB >> 30569600

Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway.

Václav Němec1,2, Michaela Hylsová1,2, Lukáš Maier1,2, Jana Flegel3, Sonja Sievers3, Slava Ziegler3, Martin Schröder4, Benedict-Tilman Berger4, Apirat Chaikuad4, Barbora Valčíková2,5, Stjepan Uldrijan2,5, Stanislav Drápela2,6, Karel Souček2,6, Herbert Waldmann3, Stefan Knapp4, Kamil Paruch1,2.   

Abstract

Reported is the identification of the furo[3,2-b]pyridine core as a novel scaffold for potent and highly selective inhibitors of cdc-like kinases (CLKs) and efficient modulators of the Hedgehog signaling pathway. Initially, a diverse target compound set was prepared by synthetic sequences based on chemoselective metal-mediated couplings, including assembly of the furo[3,2-b]pyridine scaffold by copper-mediated oxidative cyclization. Optimization of the subseries containing 3,5-disubstituted furo[3,2-b]pyridines afforded potent, cell-active, and highly selective inhibitors of CLKs. Profiling of the kinase-inactive subset of 3,5,7-trisubstituted furo[3,2-b]pyridines revealed sub-micromolar modulators of the Hedgehog pathway.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biological activity; chemical probes; heterocycles; inhibitors; kinases

Year:  2018        PMID: 30569600     DOI: 10.1002/anie.201810312

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  6 in total

1.  Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation*.

Authors:  Guoli He; Benjamin List; Mathias Christmann
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-01       Impact factor: 15.336

2.  Small Molecule Intervention in a Protein Kinase C-Gli Transcription Factor Axis.

Authors:  UyenPhuong Tran; Grace C Zhang; Ryan Eom; Kelvin L Billingsley; Alison E Ondrus
Journal:  ACS Chem Biol       Date:  2020-06-08       Impact factor: 5.100

Review 3.  Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential.

Authors:  Paula Martín Moyano; Václav Němec; Kamil Paruch
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

4.  Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases.

Authors:  Dabbugoddu Brahmaiah; Anagani Kanaka Durga Bhavani; Pasula Aparna; Nangunoori Sampath Kumar; Hélène Solhi; Rémy Le Guevel; Blandine Baratte; Thomas Robert; Sandrine Ruchaud; Stéphane Bach; Surender Singh Jadav; Chada Raji Reddy; Paul Mosset; Nicolas Gouault; Nicolas Levoin; René Grée
Journal:  Molecules       Date:  2022-09-20       Impact factor: 4.927

5.  CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells.

Authors:  Monika Štětková; Kateřina Growková; Petr Fojtík; Barbora Valčíková; Veronika Palušová; Amandine Verlande; Radek Jorda; Vladimír Kryštof; Václav Hejret; Panagiotis Alexiou; Vladimír Rotrekl; Stjepan Uldrijan
Journal:  Cell Death Dis       Date:  2020-09-15       Impact factor: 8.469

Review 6.  Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.

Authors:  Mattias F Lindberg; Laurent Meijer
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.